Tag: influenza diagnostic market cagr

  • Influenza Diagnostic Market Analysis 2026: Market Size, Growth Trends And Industry Outlook

    Influenza Diagnostic Market Analysis 2026: Market Size, Growth Trends And Industry Outlook

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Influenza Diagnostic Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

    The influenza diagnostic market size has experienced robust growth over recent years. It is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, with a compound annual growth rate (CAGR) of 8.3%. This historical growth can be ascribed to elements such as seasonal influenza outbreaks, the prevalent use of rapid antigen tests, the development of hospital laboratory infrastructure, government influenza surveillance programs, and heightened awareness of early flu diagnosis.

    The influenza diagnostic market size is anticipated to experience substantial expansion over the next few years, reaching $4.19 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.8%. This projected growth stems from several factors, including the increasing occurrence of influenza epidemics, a rising requirement for precise molecular diagnostics, the broadening of point-of-care testing infrastructure, enhanced public health readiness programs, and advancements in rapid diagnostic assays. Significant trends expected during this period encompass a surging demand for swift influenza testing, greater adoption of molecular diagnostic techniques, an increasing preference for point-of-care flu diagnostics, the expansion of seasonal and pandemic surveillance testing, and continuous improvements in the sensitivity and specificity of tests.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=72765500&type=smp&name=Influenza%20Diagnostic%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Influenza Diagnostic Market Demand Drivers Opening New Revenue Streams

    Increased investment in research on influenza diagnostics is anticipated to stimulate the expansion of the influenza diagnostic market moving forward. Funding for research on influenza diagnostics involves financial resources provided by government agencies, institutions, and various organizations to back scientific investigations aimed at developing, improving, and verifying methods and technologies for identifying influenza viruses. The rise in funding for influenza research is largely influenced by lessons from the COVID-19 pandemic and concerns regarding future respiratory disease outbreaks, as health authorities acknowledge the critical necessity of rapid and accurate diagnostic capabilities to avert widespread transmission and enable prompt public health interventions. Augmented research funding facilitates the advancement and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and enhanced laboratory procedures that allow for faster and more precise identification of influenza strains in clinical settings. For example, in October 2024, as per the Department of Health and Aged Care, an Australia-based government organization responsible for health research, funding, promotion, and regulation, the Australian Government is allocating $95 million to combat avian influenza, thereby protecting agriculture, wildlife, and the economy. Therefore, greater funding for research in influenza diagnostics is fueling the growth of the influenza diagnostic market.

    Influenza Diagnostic Market Segment Landscape And Growth Outlook

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Influenza Diagnostic Market Trends Powering Strategic Industry Growth

    Leading firms within the influenza diagnostic market are creating advanced solutions, including the Lucira COVID-19 & Flu Home Test, designed for concurrent, rapid qualitative detection. This Lucira COVID-19 and Flu Home Test functions as a disposable, at-home kit, delivering results from user-collected nasal swab samples in approximately 30 minutes. As an illustration, during February 2023, Pfizer Inc., a pharmaceutical company based in the US, secured approval for its Lucira COVID-19 & Flu Home Test. The test is capable of identifying influenza A and B, widely recognized as the flu, along with SARS-CoV-2, the pathogen responsible for COVID-19.

    Influenza Diagnostic Market Competitive Landscape: Who Leads The Industry?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    View The Full Influenza Diagnostic Market Report:

    https://thebusinessresearchcompany.com/report/Influenza-Diagnostic-Global-Market-Report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Influenza Diagnostic Market Geographic Spread And Regional Opportunities

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza Diagnostic Market Analysis 2026: Market Size, Growth Trends And Industry Outlook

    Influenza Diagnostic Market Analysis 2026: Market Size, Growth Trends And Industry Outlook

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Influenza Diagnostic Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

    The influenza diagnostic market size has experienced robust growth over recent years. It is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, with a compound annual growth rate (CAGR) of 8.3%. This historical growth can be ascribed to elements such as seasonal influenza outbreaks, the prevalent use of rapid antigen tests, the development of hospital laboratory infrastructure, government influenza surveillance programs, and heightened awareness of early flu diagnosis.

    The influenza diagnostic market size is anticipated to experience substantial expansion over the next few years, reaching $4.19 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.8%. This projected growth stems from several factors, including the increasing occurrence of influenza epidemics, a rising requirement for precise molecular diagnostics, the broadening of point-of-care testing infrastructure, enhanced public health readiness programs, and advancements in rapid diagnostic assays. Significant trends expected during this period encompass a surging demand for swift influenza testing, greater adoption of molecular diagnostic techniques, an increasing preference for point-of-care flu diagnostics, the expansion of seasonal and pandemic surveillance testing, and continuous improvements in the sensitivity and specificity of tests.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=72765500&type=smp&name=Influenza%20Diagnostic%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Influenza Diagnostic Market Demand Drivers Opening New Revenue Streams

    Increased investment in research on influenza diagnostics is anticipated to stimulate the expansion of the influenza diagnostic market moving forward. Funding for research on influenza diagnostics involves financial resources provided by government agencies, institutions, and various organizations to back scientific investigations aimed at developing, improving, and verifying methods and technologies for identifying influenza viruses. The rise in funding for influenza research is largely influenced by lessons from the COVID-19 pandemic and concerns regarding future respiratory disease outbreaks, as health authorities acknowledge the critical necessity of rapid and accurate diagnostic capabilities to avert widespread transmission and enable prompt public health interventions. Augmented research funding facilitates the advancement and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and enhanced laboratory procedures that allow for faster and more precise identification of influenza strains in clinical settings. For example, in October 2024, as per the Department of Health and Aged Care, an Australia-based government organization responsible for health research, funding, promotion, and regulation, the Australian Government is allocating $95 million to combat avian influenza, thereby protecting agriculture, wildlife, and the economy. Therefore, greater funding for research in influenza diagnostics is fueling the growth of the influenza diagnostic market.

    Influenza Diagnostic Market Segment Landscape And Growth Outlook

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Influenza Diagnostic Market Trends Powering Strategic Industry Growth

    Leading firms within the influenza diagnostic market are creating advanced solutions, including the Lucira COVID-19 & Flu Home Test, designed for concurrent, rapid qualitative detection. This Lucira COVID-19 and Flu Home Test functions as a disposable, at-home kit, delivering results from user-collected nasal swab samples in approximately 30 minutes. As an illustration, during February 2023, Pfizer Inc., a pharmaceutical company based in the US, secured approval for its Lucira COVID-19 & Flu Home Test. The test is capable of identifying influenza A and B, widely recognized as the flu, along with SARS-CoV-2, the pathogen responsible for COVID-19.

    Influenza Diagnostic Market Competitive Landscape: Who Leads The Industry?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    View The Full Influenza Diagnostic Market Report:

    https://thebusinessresearchcompany.com/report/Influenza-Diagnostic-Global-Market-Report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Influenza Diagnostic Market Geographic Spread And Regional Opportunities

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza Diagnostic Market Opportunities Are Emerging Beyond Traditional Growth Areas

    Influenza Diagnostic Market Opportunities Are Emerging Beyond Traditional Growth Areas

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Influenza Diagnostic Market Value Analysis: What Growth Is Expected Over The Forecast Period?

    The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.87 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to seasonal influenza outbreaks, widespread use of rapid antigen tests, growth of hospital laboratory infrastructure, government influenza surveillance programs, increased awareness of early flu diagnosis.

    The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $4.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising frequency of influenza epidemics, growing demand for accurate molecular diagnostics, expansion of point-of-care testing facilities, increased public health preparedness initiatives, technological advancements in rapid diagnostic assays. Major trends in the forecast period include rising demand for rapid influenza testing, increased adoption of molecular diagnostic methods, growing preference for point-of-care flu diagnostics, expansion of seasonal and pandemic surveillance testing, continuous improvement in test sensitivity and specificity.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    Influenza Diagnostic Market Growth Factors: Which Forces Are Supporting Market Expansion?

    The increasing funding for research on influenza diagnostics is expected to propel the growth of the influenza diagnostic market going forward. Funding for research on influenza diagnostics refers to financial resources allocated by government agencies, institutions, and organizations to support scientific investigations aimed at developing, improving, and validating methods and technologies for detecting and identifying influenza viruses. The rising funding for influenza research is driven by lessons learned from the COVID-19 pandemic and concerns about future respiratory disease outbreaks, as health authorities recognize the critical importance of rapid and accurate diagnostic capabilities to prevent widespread transmission and enable timely public health interventions. Growing research funding supports the development and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and improved laboratory procedures that enable faster and more accurate identification of influenza strains in clinical settings. For instance, in October 2024, according to the Department of Health and Aged Care, a Australia-based government organization responsible for health research, funding, promotion and regulation, the Australian Government is allocating $95 million to combat avian influenza, protecting agriculture, wildlife, and the economy. Therefore, increasing funding for research on influenza diagnostics is driving the growth of the influenza diagnostic market.

    Influenza Diagnostic Market Categorization By Product Type And Application

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Influenza Diagnostic Market Industry Trends: What Changes Are Reshaping Demand?

    Major companies operating in the influenza diagnostic market are developing innovative products such as Lucira COVID-19 & Flu Home Test for the simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. For instance, in February 2023, Pfizer Inc., a US-based pharmaceutical company received approval for the Lucira COVID-19 & Flu Home Test. The test can detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.

    Influenza Diagnostic Market Company Landscape And Strategic Competition

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Access The Complete Influenza Diagnostic Market Report:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Influenza Diagnostic Market Largest Region: Which Geography Holds The Highest Market Share?

    North Americawas the largest region in the influenza diagnostics market in 2025. Western Europewas the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza Diagnostic Market Expected To Witness Revenue Growth Toward $4.18 Billion By 2030

    Influenza Diagnostic Market Expected To Witness Revenue Growth Toward $4.18 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Increase In Market Value Is Predicted For The Influenza Diagnostic Market During The 2026–2030 Period?

    The influenza diagnostic market has recently experienced significant expansion. This market is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. The historical expansion of this market stems from several factors, including seasonal influenza outbreaks, the broad adoption of rapid antigen tests, the development of hospital laboratory infrastructure, governmental influenza surveillance programs, and a heightened understanding of the importance of early flu diagnosis.

    The influenza diagnostic market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $4.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This projected growth during the forecast period can be attributed to several factors, including the increasing occurrence of influenza epidemics, a heightened need for precise molecular diagnostics, the proliferation of point-of-care testing facilities, enhanced public health readiness initiatives, and innovations in rapid diagnostic assays. Key trends anticipated during the forecast period encompass an escalating demand for swift influenza testing, a greater embrace of molecular diagnostic techniques, an increasing inclination towards point-of-care flu diagnostics, the broadening of seasonal and pandemic surveillance testing, and ongoing enhancements in test sensitivity and specificity.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Core Drivers Are Transforming The Influenza Diagnostic Market?

    The influenza diagnostic market is anticipated to expand due to the rising financial investment in influenza diagnostics research. This funding represents financial contributions from government bodies, institutions, and various organizations to back scientific studies focused on creating, enhancing, and validating techniques and technologies for identifying influenza viruses. This increased investment in influenza research stems from insights gained during the COVID-19 pandemic and worries about potential future respiratory outbreaks, given that health authorities understand the crucial role of quick and precise diagnostic tools in preventing broad transmission and facilitating prompt public health responses. Elevated research funding aids the creation and market introduction of sophisticated testing technologies, molecular assays, point-of-care instruments, and refined laboratory protocols, all of which allow for quicker and more accurate identification of influenza strains in medical environments. As an illustration, in October 2024, the Department of Health and Aged Care, an Australia-based governmental entity overseeing health research, funding, promotion, and regulation, reported that the Australian Government is dedicating $95 million to address avian influenza, thereby safeguarding agriculture, wildlife, and the economy. Consequently, the enhanced funding for influenza diagnostics research is propelling the expansion of the influenza diagnostic market.

    How Is The Influenza Diagnostic Market Distributed Across Key Segments?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Which Trends Are Contributing To Changes In The Influenza Diagnostic Market?

    Major companies operating within the influenza diagnostic market are engaged in the development of innovative products, such as the Lucira COVID-19 & Flu Home Test, intended for simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test functions as a single-use at-home testing kit, delivering results from self-collected nasal swab samples in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US-based pharmaceutical company, obtained approval for the Lucira COVID-19 & Flu Home Test. This test is capable of detecting both influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus causing COVID-19.

    Which Organizations Are Operating Within The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Access The Complete Influenza Diagnostic Market Report:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Regional Market Leads The Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Influenza Diagnostic Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2026, By The Business Research Company

    Virtual Clinical Trials Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

    Clinical Trial Supplies Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

    Clinical Trial Management Systems Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-trial-management-systems-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza diagnostic market highlights key trends and growth drivers

    Influenza diagnostic market highlights key trends and growth drivers

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Large Will The Influenza Diagnostic Market Be By 2030 Compared To Its 2026 Market Size?

    The influenza diagnostic market has experienced robust expansion over recent years. The market is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this historical growth include seasonal influenza outbreaks, the widespread adoption of rapid antigen tests, the expansion of hospital laboratory infrastructure, government influenza surveillance programs, and heightened awareness regarding early flu diagnosis.

    The influenza diagnostic market size is projected to experience substantial expansion in the coming years. By 2030, its valuation is set to reach $4.19 billion, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period stems from factors such as an increasing occurrence of influenza epidemics, a heightened need for precise molecular diagnostics, the proliferation of point-of-care testing sites, enhanced public health readiness programs, and innovations in rapid diagnostic assay technology. Key developments expected within the forecast timeframe encompass an escalating demand for quick influenza tests, wider acceptance of molecular diagnostic approaches, a growing inclination towards point-of-care flu diagnostic solutions, the broadening scope of seasonal and pandemic surveillance testing, and ongoing enhancements in test sensitivity and specificity.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    What Major Factors Are Driving The Influenza Diagnostic Market Forward?

    The increasing financial investment in research for influenza diagnostics is anticipated to drive the expansion of the influenza diagnostic market moving forward. This funding represents monetary support allocated by government agencies, institutions, and organizations to facilitate scientific investigations aimed at developing, improving, and validating methods and technologies for identifying influenza viruses. The growth in influenza research funding is motivated by insights from the COVID-19 pandemic and concerns about potential future respiratory disease outbreaks, as health authorities recognize the crucial importance of rapid and accurate diagnostic tools to prevent broad transmission and enable timely public health interventions. This augmented research funding aids in the development and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and improved laboratory procedures, which allow for faster and more accurate detection of influenza strains in clinical settings. For instance, in October 2024, the Department of Health and Aged Care, an Australia-based government organization responsible for health research, funding, promotion, and regulation, reported that the Australian Government is dedicating $95 million to combat avian influenza, thereby protecting agriculture, wildlife, and the economy. Therefore, the growing funding for research on influenza diagnostics is fueling the growth of the influenza diagnostic market.

    What Are The Key Segment Divisions In The Influenza Diagnostic Market Segment Structure?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Which Trends Are Impacting The Progress Of The Influenza Diagnostic Market?

    Leading companies in the influenza diagnostic market are developing innovative products, such as the Lucira COVID-19 & Flu Home Test, to enable rapid and simultaneous qualitative detection. This Lucira COVID-19 and Flu Home Test is a single-use, at-home kit that delivers results from self-collected nasal swab samples in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US-based pharmaceutical company, secured approval for the Lucira COVID-19 & Flu Home Test. The test is designed to identify influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.

    Which Organizations Are Engaged In The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Get The Full Influenza Diagnostic Market Report:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Region Is The Leading Market For The Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Influenza Diagnostic Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2026, By The Business Research Company

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Influenza Vaccines Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

    Influenza Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Influenza Diagnostic Industry Trends and Market Growth Forecast for 2026–2030

    Global Influenza Diagnostic Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Value Is Expected For The Influenza Diagnostic Market At The End Of The 2026–2030 Forecast Period?

    The influenza diagnostic market has demonstrated substantial growth in recent years. This market is expected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion has been propelled by elements like seasonal influenza outbreaks, the extensive adoption of rapid antigen tests, enhancements in hospital laboratory infrastructure, government initiatives for influenza surveillance, and increased recognition of the importance of early flu diagnosis.

    The influenza diagnostic market size is projected to experience robust expansion in the upcoming years. By 2030, this market is anticipated to reach $4.19 billion, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the projected timeframe include an increase in influenza epidemic occurrences, a heightened need for precise molecular diagnostic tools, the broadening of point-of-care testing access, enhanced public health readiness programs, and innovations in quick diagnostic assays. Key trends expected within the forecast period encompass a surge in demand for swift influenza testing, greater integration of molecular diagnostic techniques, a developing preference for point-of-care flu detection, the widening scope of seasonal and pandemic surveillance testing, and ongoing enhancements in the accuracy and reliability of tests.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Primary Drivers Are Shaping The Development Of The Influenza Diagnostic Market?

    The expansion of the influenza diagnostic market is anticipated to be fueled by the growing investment in research concerning influenza diagnostics. This funding refers to financial resources provided by governmental bodies, institutions, and various organizations to back scientific studies aimed at developing, refining, and validating methods and technologies for identifying influenza viruses. The surge in funding for influenza research is primarily motivated by lessons learned from the COVID-19 pandemic and concerns over future respiratory disease outbreaks. Health authorities recognize the crucial importance of rapid and accurate diagnostic capabilities to prevent widespread transmission and enable timely public health interventions. This increased research funding facilitates the development and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and enhanced laboratory procedures, which collectively allow for faster and more accurate identification of influenza strains in clinical settings. For example, in October 2024, the Department of Health and Aged Care, an Australia-based government organization responsible for health research, funding, promotion, and regulation, reported that the Australian Government is dedicating $95 million to combat avian influenza, thereby protecting agriculture, wildlife, and the economy. Thus, the escalating funding for research on influenza diagnostics is a key driver for the growth of the influenza diagnostic market.

    What Segment Types Make Up The Influenza Diagnostic Market?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    What Major Market Trends Are Driving Changes In The Influenza Diagnostic Market?

    Leading companies in the influenza diagnostic market are developing innovative products like the Lucira COVID-19 & Flu Home Test for swift, concurrent qualitative detection. This Lucira COVID-19 and Flu Home Test is a single-use, at-home kit that delivers results from user-collected nasal swab samples in roughly 30 minutes. For example, in February 2023, the US-based pharmaceutical firm Pfizer Inc. received approval for the Lucira COVID-19 & Flu Home Test. The test is capable of detecting influenza A and B, known as the flu, and SARS-CoV-2, the virus responsible for COVID-19.

    Who Are The Key Players Driving Competition In The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Read the full influenza diagnostic market report here:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    How Does The Influenza Diagnostic Market Perform Across Major Global Regions?

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Influenza Diagnostic Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2026, By The Business Research Company

    Virtual Clinical Trials Global Market Report

    https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

    Clinical Trial Supplies Global Market Report

    https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

    Clinical Trial Management Systems Global Market Report

    https://www.thebusinessresearchcompany.com/report/clinical-trial-management-systems-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza Diagnostic Sector Forecast Shows Robust Momentum, Climbing to $4.18 Billion With 7.8% CAGR

    Influenza Diagnostic Sector Forecast Shows Robust Momentum, Climbing to $4.18 Billion With 7.8% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the influenza diagnostic market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Influenza Diagnostic Market between 2026 and 2030?

    The influenza diagnostic market has experienced substantial growth recently. It is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion has been driven by factors such as seasonal influenza outbreaks, the widespread adoption of rapid antigen tests, the development of hospital laboratory infrastructure, governmental influenza surveillance initiatives, and heightened awareness regarding early flu diagnosis.

    The influenza diagnostic market is anticipated to experience robust expansion over the coming years. This market is projected to reach $4.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the projection period include an increasing incidence of influenza epidemics, the escalating need for precise molecular diagnostics, the proliferation of point-of-care testing sites, heightened public health readiness efforts, and innovations in rapid diagnostic assay technologies. Key trends observed during this period are the surging requirement for quick influenza tests, wider acceptance of molecular diagnostic techniques, a developing preference for point-of-care flu diagnostic solutions, the broadening scope of seasonal and pandemic surveillance testing, and ongoing enhancements in test sensitivity and specificity.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Influenza Diagnostic Market?

    Expanding financial investment into influenza diagnostics research is projected to advance the expansion of the influenza diagnostic market moving ahead. This funding encompasses monetary allocations from governmental bodies, institutions, and various organizations, purposed to back scientific inquiries focused on innovating, refining, and confirming techniques and technologies for identifying and detecting influenza viruses. The uptick in funding for influenza studies stems from insights gained during the COVID-19 pandemic and worries about potential future respiratory disease epidemics, as health authorities acknowledge the vital necessity of swift and precise diagnostic tools to avert extensive spread and facilitate prompt public health actions. Enhanced research investment aids in the creation and market introduction of sophisticated testing methods, molecular analyses, rapid point-of-care devices, and refined laboratory protocols, all of which allow for quicker and more precise identification of influenza strains within clinical environments. For example, in October 2024, as reported by the Department of Health and Aged Care, a government entity in Australia overseeing health research, funding, promotion, and regulation, the Australian Government is committing $95 million to address avian influenza, thereby safeguarding agriculture, wildlife, and the economy. Consequently, the increased financial support for influenza diagnostics research is fueling the expansion of the influenza diagnostic market.

    What Segments Are Included Within The Influenza Diagnostic Market?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    How Are New Market Trends Shaping The Landscape Of The Influenza Diagnostic Market?

    Companies operating within the influenza diagnostic market are actively developing innovative products, such as the Lucira COVID-19 & Flu Home Test, intended for the rapid and simultaneous qualitative detection of multiple viruses. The Lucira COVID-19 and Flu Home Test is designed as a single-use kit for at-home use, providing results from self-collected nasal swab samples in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US-based pharmaceutical company, secured approval for the Lucira COVID-19 & Flu Home Test. This diagnostic tool is capable of identifying influenza A and B, commonly known as the flu, as well as SARS-CoV-2, the virus responsible for COVID-19.

    Who Are The Major Companies Operating In The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Influenza Diagnostic Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2026, By The Business Research Company

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Influenza Vaccines Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

    Influenza Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Influenza Diagnostic Sector Forecast Shows Robust Momentum, Climbing to $4.18 Billion With 7.8% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the influenza diagnostic market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Influenza Diagnostic Market between 2026 and 2030?

    The influenza diagnostic market has experienced substantial growth recently. It is projected to expand from $2.87 billion in 2025 to $3.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion has been driven by factors such as seasonal influenza outbreaks, the widespread adoption of rapid antigen tests, the development of hospital laboratory infrastructure, governmental influenza surveillance initiatives, and heightened awareness regarding early flu diagnosis.

    The influenza diagnostic market is anticipated to experience robust expansion over the coming years. This market is projected to reach $4.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the projection period include an increasing incidence of influenza epidemics, the escalating need for precise molecular diagnostics, the proliferation of point-of-care testing sites, heightened public health readiness efforts, and innovations in rapid diagnostic assay technologies. Key trends observed during this period are the surging requirement for quick influenza tests, wider acceptance of molecular diagnostic techniques, a developing preference for point-of-care flu diagnostic solutions, the broadening scope of seasonal and pandemic surveillance testing, and ongoing enhancements in test sensitivity and specificity.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Influenza Diagnostic Market?

    Expanding financial investment into influenza diagnostics research is projected to advance the expansion of the influenza diagnostic market moving ahead. This funding encompasses monetary allocations from governmental bodies, institutions, and various organizations, purposed to back scientific inquiries focused on innovating, refining, and confirming techniques and technologies for identifying and detecting influenza viruses. The uptick in funding for influenza studies stems from insights gained during the COVID-19 pandemic and worries about potential future respiratory disease epidemics, as health authorities acknowledge the vital necessity of swift and precise diagnostic tools to avert extensive spread and facilitate prompt public health actions. Enhanced research investment aids in the creation and market introduction of sophisticated testing methods, molecular analyses, rapid point-of-care devices, and refined laboratory protocols, all of which allow for quicker and more precise identification of influenza strains within clinical environments. For example, in October 2024, as reported by the Department of Health and Aged Care, a government entity in Australia overseeing health research, funding, promotion, and regulation, the Australian Government is committing $95 million to address avian influenza, thereby safeguarding agriculture, wildlife, and the economy. Consequently, the increased financial support for influenza diagnostics research is fueling the expansion of the influenza diagnostic market.

    What Segments Are Included Within The Influenza Diagnostic Market?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

    2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    How Are New Market Trends Shaping The Landscape Of The Influenza Diagnostic Market?

    Companies operating within the influenza diagnostic market are actively developing innovative products, such as the Lucira COVID-19 & Flu Home Test, intended for the rapid and simultaneous qualitative detection of multiple viruses. The Lucira COVID-19 and Flu Home Test is designed as a single-use kit for at-home use, providing results from self-collected nasal swab samples in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US-based pharmaceutical company, secured approval for the Lucira COVID-19 & Flu Home Test. This diagnostic tool is capable of identifying influenza A and B, commonly known as the flu, as well as SARS-CoV-2, the virus responsible for COVID-19.

    Who Are The Major Companies Operating In The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Influenza Diagnostic Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2026, By The Business Research Company

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Influenza Vaccines Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

    Influenza Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Influenza Diagnostic Market Forecast 2029: Size, Share, and Competitive Landscape

    Global Influenza Diagnostic Market Forecast 2029: Size, Share, and Competitive Landscape

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Is The Influenza Diagnostic Market Expected To Grow In Terms Of Size?

    There has been consistent growth in the influenza diagnostic market size over the past few years. The market is projected to expand from $2.73 billion in 2024 to $2.87 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the growth witnessed in the previous years include developments in e-commerce, labor scarcities, enhanced automation and productivity, improvements in supply chain management, increased labor costs, and governmental backing for automation and robotics.

    Expectations are high for considerable expansion in the influenza diagnostic market in the coming years. Projections see the market swelling to $3.9 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. The predicted growth within the forecast period can be credited to factors like customization, scalability, environmental and sustainability objectives, a desire to enhance operational performance, and the necessity to align with modern supply chain dynamics. The projected period is also likely to witness major trends including the incorporation of advanced technology, robotic selection and packaging, autonomous mobile robotics, real-time data processing and analytics, AI-powered decision making, collaborative robotics, and breakthroughs in robotic technology.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Market Forces Are Contributing To The Growth Of The Influenza Diagnostic Market?

    The expansion of the influenza diagnostic market is anticipated to be fueled by the growing prevalence of rapid diagnostic tests. These tests, vital for confirming or denying the existence of a disease or condition, are seeing an increase due to their ability to yield swift, accurate results in the healthcare sector. Rapid influenza diagnostic tests (RIDTs), in particular, can identify influenza viral antigens within 10-15 minutes, boasting a moderate sensitivity of 50-70%. For instance, the Australian Institute of Health and Welfare confirmed that from 2021-22 to 2022-23, the quantity of diagnostic imaging services surged from 28.4 million to 29.7 million. Therefore, the use of rapid diagnostic tests plays a significant role in promoting the influenza diagnostic market’s growth.

    How Is The Influenza Diagnostic Market Segmented Across Key Categories?

    The influenza diagnosticmarket covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture; Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

    What Future-Focused Trends Are Anticipated In The Influenza Diagnostic Market?

    Leading firms in the influenza diagnostic market have initiated the production of ground-breaking items like Lucira COVID-19 & Flu Home Test that delivers speedy qualitative detection collectively. The Lucira COVID-19 and Flu Home Test, a single-use test kit for domestic use, generates outcomes from nasal swabs collected by individuals in about 30 minutes. For example, in February 2023, Pfizer Inc., a pharmaceutical company based in the US, gained official approval for the Lucira COVID-19 & Flu Home Test. This test is capable of identifying both Influenza A and B, also referred to as the flu, and SARS-CoV-2, the originating virus of COVID-19.

    Who Are The Major Stakeholders Operating In The Influenza Diagnostic Market?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    How Do Regional Dynamics Influence The Influenza Diagnostic Market Performance?

    North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2025, By The Business Research Company

    Immunofluorescence Assay Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Molecular Diagnostics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

    Molecular Diagnostics Devices And Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

    Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Projected CAGR for the Influenza Diagnostic Market Size from 2025 to 2034?

    In the past few years, there has been a consistent growth in the influenza diagnostic market size. It is projected to expand from $2.73 billion in 2024 to $2.87 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The unprecedented growth during the historic period is due to factors such as the expansion of e-commerce, labor shortages, increased automation and productivity, optimization of the supply chain, escalating labor costs, and governmental backing for automation and robotics.

    The market for influenza diagnostics is predicted to witness significant expansion in the upcoming years. It is estimated to reach a value of$3.9 billion” by 2029, growing at a Compound Annual Growth Rate (CAGR) of 8.0%. This growth, projected for the forecast period, can be linked to factors such as customization and scalability, achieving environmental and sustainability aims, enhancing operational efficiency, and addressing the needs of contemporary supply chain dynamics. The foreseeable future is set to observe major trends such as the incorporation of state-of-the-art technology, robotic assembling and packaging, autonomous mobile robots, live data and analytics, AI-powered decision making, cooperative robots, as well as advancements in the realm of robotic technology.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Are the Core Market Drivers Propelling Growth in the Influenza Diagnostic Industry?

    The influenza diagnostic market is predicted to grow significantly owing to the increased usage of rapid diagnostic tests. These are medical techniques used to determine or exclude the possibility of a disease or condition. There has been a noteworthy rise in the demand for rapid diagnostic tests owing to their fast, accurate healthcare results. Rapid influenza diagnostic tests, which can identify viral antigens related to influenza in just 10-15 minutes with a moderate sensitivity of 50-70%, are significant contributors. For example, in July 2024, the Australian Institute of Health and Welfare reported that the number of diagnostic imaging services in Australia increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, these swift diagnostic tests are fueling the expansion of the influenza diagnostic market.

    How Is the Influenza Diagnostic Market Segmented?

    The influenza diagnosticmarket covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture; Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Which Regions Are Driving the Next Phase of the Influenza Diagnostic Market Growth?

    North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Market Trends and Innovations Are Shaping the Future of the Influenza Diagnostic Industry?

    Top firms in the influenza diagnostic market, such as Lucira, are revolutionizing the industry by introducing innovative products like the COVID-19 & Flu Home Test. This one-time use, at-home test kit, can deliver results from nasal swab samples collected by the individual in approximately 30 minutes. To provide an example, Pfizer Inc., an American pharmaceutical corporation, gained approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify influenza A and B – typically referred to as the flu – as well as SARS-CoV-2, the virus responsible for COVID-19.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    How Is the Influenza Diagnostic Market Defined and What Are Its Core Parameters?

    Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model